```html

Myrticiform Rash – A Comprehensive Guide

What is Myrticiform Rash?

A myrticiform rash is a skin eruption that closely resembles urticaria (hives) in its appearance. The word “myrticiform” literally means “shaped like a hive.” The rash typically presents as raised, erythematous (red) welts or plaques that may coalesce into larger patches, often with a well‑defined edge and a blanching (fading) center when pressed. Unlike classic urticaria, the lesions of a myrticiform rash may persist longer (several hours to a few days) and can be associated with deeper dermal inflammation.

Because it looks like hives, it is sometimes mistakenly called “hive‑like rash.” However, the underlying causes can be broader, ranging from allergic reactions to systemic illnesses. Recognizing the pattern and accompanying clues is essential for proper management.

Common Causes

Below are the most frequently reported conditions that can produce a myrticiform rash. The list includes allergic, infectious, autoimmune, and drug‑related triggers.

• Allergic reactions – foods (nuts, shellfish, eggs), insect stings, latex, or environmental allergens.
• Medication‑induced urticaria – antibiotics (penicillins, sulfonamides), NSAIDs, ACE inhibitors, and contrast dyes.
• Viral infections – hepatitis B & C, Epstein‑Barr virus, HIV, and parvovirus B19.
• Bacterial infections – streptococcal pharyngitis, Lyme disease (Borrelia burgdorferi), and syphilis.
• Parasitic infestations – scabies, strongyloidiasis, and helminth infections.
• Autoimmune diseases – systemic lupus erythematosus, dermatomyositis, and vasculitis (e.g., cryoglobulinemic vasculitis).
• Physical urticarias – dermographism (skin writing), cold‑induced urticaria, cholinergic urticaria, and pressure‑induced urticaria.
• Endocrine disorders – thyroid disease (both hyper‑ and hypothyroidism) and mast cell activation syndromes.
• Contact dermatitis – exposure to chemicals, metals (nickel), or plants (poison ivy, oak).
• Idiopathic chronic urticaria – no identifiable trigger after thorough evaluation.

Associated Symptoms

While a myrticiform rash can appear in isolation, it is often accompanied by other clinical features that help narrow the cause.

• Itching (pruritus) – ranging from mild to severe.
• Burning or stinging sensations.
• Swelling of lips, eyelids, or extremities (angio‑edema).
• Fever, malaise, or chills – suggestive of infection.
• Joint pain or swelling – common in autoimmune or viral etiologies.
• Gastrointestinal symptoms (nausea, abdominal pain, diarrhea) – frequently seen with food allergies or certain infections.
• Respiratory symptoms (wheezing, shortness of breath) – may signal anaphylaxis.
• Neurologic complaints (headache, dizziness) – can accompany systemic illnesses like Lyme disease.

When to See a Doctor

Most myrticiform rashes are benign and resolve with simple measures, but some situations warrant prompt medical attention.

• Rash persisting longer than 24–48 hours without improvement.
• Rapid spread to the face, neck, or trunk.
• Development of swelling of the tongue, throat, or lips.
• Difficulty breathing, wheezing, or a feeling of throat tightness.
• Accompanying fever > 101 °F (38.3 °C) or chills.
• Severe itching that interferes with sleep or daily activities.
• New‑onset rash after starting a medication or after a known exposure (e.g., insect bite).
• Signs of infection: pus, crusting, or a painful, warm area.

Diagnosis

Evaluation begins with a careful history and physical exam, followed by targeted tests when needed.

1. Clinical History

• Onset, duration, and pattern of the rash.
• Recent foods, medications, travel, insect bites, or contact with chemicals.
• Associated systemic symptoms (fever, arthralgia, GI upset).
• Personal or family history of allergies, autoimmune disease, or mast cell disorders.

2. Physical Examination

• Distribution, size, shape, and color of lesions.
• Presence of wheals that blanch with pressure (Darier’s sign for mastocytosis).
• Signs of angio‑edema or other organ involvement.

3. Laboratory and Imaging Studies

• Complete blood count (CBC) – eosinophilia may point to allergic or parasitic causes.
• Serum IgE level – elevated in atopic or chronic urticaria.
• C‑reactive protein (CRP) / ESR – markers of inflammation; high levels suggest infection or vasculitis.
• Specific IgE or skin‑prick testing – for suspected food or inhalant allergens.
• Autoimmune panel – ANA, anti‑dsDNA, complement levels if lupus or vasculitis suspected.
• Infectious work‑up – throat culture, viral serologies, Lyme serology, hepatitis panel as indicated.
• Biopsy – rare, but a skin punch biopsy can differentiate urticaria from vasculitis or mastocytosis.

Treatment Options

Treatment is tailored to the identified cause and severity of symptoms.

1. General Measures

• Identify and avoid known triggers (e.g., specific foods, medications, temperature extremes).
• Cool compresses or cool baths to relieve itching.
• Loose, breathable clothing (cotton) to reduce friction.

2. Pharmacologic Therapy

• Second‑generation antihistamines (cetirizine, loratadine, fexofenadine) – first‑line for symptomatic relief; less sedating.
• First‑generation antihistamines (diphenhydramine, hydroxyzine) – useful at night for severe itching but cause drowsiness.
• H2‑blockers (ranitidine, famotidine) – sometimes added for refractory urticaria.
• Systemic corticosteroids – short courses (e.g., prednisone 10‑20 mg daily for 5‑7 days) for acute severe flares or when an underlying systemic disease is being treated.
• Leukotriene receptor antagonists (montelukast) – adjunct in chronic urticaria or aspirin‑induced cases.
• Biologic agents – omalizumab (anti‑IgE) for chronic idiopathic urticaria unresponsive to antihistamines.
• Antibiotics/Antivirals – when an infectious etiology is confirmed (e.g., doxycycline for Lyme disease, acyclovir for HSV).
• Antiparasitic therapy – ivermectin or albendazole for confirmed parasitic infection.

3. Home & Lifestyle Interventions

• Daily moisturizers to maintain skin barrier integrity.
• Stress‑reduction techniques (mindfulness, yoga) – stress can exacerbate chronic urticaria.
• Maintain a symptom diary to track triggers and response to medications.

Prevention Tips

While not all myrticiform rashes are preventable, many can be avoided with simple strategies.

• Read medication labels and inform healthcare providers of any known drug allergies.
• Keep a food diary; consider an elimination diet under professional supervision if food allergy is suspected.
• Use insect repellent and wear protective clothing in endemic areas for tick‑borne diseases.
• Avoid known physical triggers – extreme cold, hot showers, tight clothing, or prolonged pressure.
• Practice good skin hygiene; promptly clean any contact dermatitis exposures (e.g., poison ivy).
• Stay up to date with vaccinations (e.g., hepatitis B, influenza) to reduce infection‑related rashes.
• Regularly review OTC products (lotions, soaps) to ensure they are fragrance‑free and hypoallergenic.

Emergency Warning Signs

Key Take‑aways

• A myrticiform rash looks like hives but can be caused by a wide range of allergic, infectious, autoimmune, and drug‑related factors.
• Most cases are self‑limited; however, persistent or rapidly spreading rashes, especially with breathing or swelling problems, require urgent medical care.
• Diagnosis relies on a detailed history, physical exam, and targeted labs; a skin biopsy is rarely needed.
• Second‑generation antihistamines are first‑line therapy; more aggressive treatments (corticosteroids, omalizumab) are reserved for severe or chronic disease.
• Prevention focuses on trigger avoidance, good skin care, and maintaining overall health.

---

References:

• Mayo Clinic. Urticaria (Hives). https://www.mayoclinic.org
• American Academy of Dermatology. Chronic urticaria: Diagnosis and treatment. https://www.aad.org
• Cleveland Clinic. Urticaria (Hives) Overview. https://my.clevelandclinic.org
• National Institute of Allergy and Infectious Diseases. Drug Allergy and Hypersensitivity. https://www.niaid.nih.gov
• World Health Organization. Vector‑borne diseases – Lyme disease. https://www.who.int

```